Resistance to PRMT5 Inhibitor Targeted Therapy in MCL [WES]
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
To identify the genomic changes underlying PRMT5 inhibitor resistance in MCL cell lines and MCL PDX Overall design: Whole exome of MCL PDX cells (untreated (n=1), short-term treated (n=1), and resistant treated (n=2)) and resistant and sensitive MCL cell lines
应用场景：
创建时间：
2024-01-30
相关数据集
Targeting tumor-macrophage interaction via the Notch2-Jag1 axis reverses tumor resistance to paclitaxel
Taxanes are widely used in chemotherapy, but intrinsic and acquired resistance limit the clinical outcomes. Studies showed tumor interaction with suppressive macrophages plays a key role in taxane res
NIAID Data Ecosystem80
YAP activation mediates acquired resistance to ALK inhibitor in ALK rearranged non–small cell lung cancer
To investigate a possible candidate for overcoming the acquired resistance to ALK-TKI, we established an in vitro model of acquired resistance to crizotinib (H3122-CR) by exposing EML4-ALK–positive H3
NIAID Data Ecosystem40
Divergent BRAF Inhibitor Resistance Mechanisms Revealed through Epigenetic Mapping. Divergent BRAF Inhibitor Resistance Mechanisms Revealed through Epigenetic Mapping
In this report, we generated eight matched pairs of vemurafenib sensitive/resistant melanoma lines and subjected these to concurrent RNA-seq and H3K27Ac ChIP-seq analysis. Globally, we identified two
NIAID Data Ecosystem30
Suppression of adaptive responses to targeted cancer therapy by transcriptional repression [RNA-seq]. Homo sapiens
Large-scale genomic profiling efforts have facilitated the characterization of molecular alterations in cancers and aided the development of targeted kinase inhibitors for a wide array of cancer types
NIAID Data Ecosystem50
Targeted sequencing of IDH1 and IDH2 genes was performed using bone marrow specimens from matched diagnosis and relapsed AML patients with IDH baseline mutation before or after IDHmut inhibitor treatment. gDNA was extracted from the bone marrow clot sections using the QuickExtract FFPE DNA extraction kit (Epicenter Biotechnologies) following the manufacturer's instructions. The exon sequences of IDH1 and IDH2 genes were PCR amplified. The DNA fragments for each exon were purified with QIAquick spin columns (Qiagen), mixed at equal molarity, and fragmented using Covaris acoustic shearing following the manufacturer’s instructions. Sonicated DNA was processed for library generation using NEBNext Ultra II DNA Kits (New England Biolabs) following the manufacturer’s protocol. Libraries with different index sequences were quantified, pooled, and sequenced on an Illumina Nextseq500 system using the 75bp high output sequencing kit.. Targeted sequencing of IDH1 and IDH2 genes in AML samples
Acquired resistance to allosteric inhibition of cancer-associated IDH mutations has been described through mutations to restore the production of oncometabolite R-2HG, yet the complete repertoire of I
NIAID Data Ecosystem30
